EGFRvIII peptide PEPvIII |
Catalog No.GC35967 |
El péptido PEPvIII de EGFRvIII es una mutación específica del tumor que se expresa ampliamente en el glioblastoma multiforme (GBM) y otras neoplasias y su expresión aumenta la tumorigenicidad. El péptido EGFRvIII representa un verdadero objetivo tumoral específico para la inmunoterapia antitumoral.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 129112-17-0
Sample solution is provided at 25 µL, 10mM.
EGFRvIII peptide (PEPvIII) is a tumor-specific mutation that is widely expressed in glioblastoma multiforme (GBM) and other neoplasms and its expression enhances tumorigenicity. EGFRvIII peptide represents a truly tumor-specific target for antitumor immunotherapy[1].
[1]. Schmittling RJ, et al. Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccines. J Immunol Methods. 2008 Nov 30;339(1):74-81.
Average Rating: 5
(Based on Reviews and 40 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *